Elisa Pose

Research interests

I am a fellow of the Liver Unit at Hospital Clínic de Barcelona. I have started my phD with the program PhD4MD in 2016 and the aim of my current research is to unveil the molecular mechanisms that drive the progression of chronic liver diseases.

Previous working experience

2012-2016: Residency in digestive Diseases at Hospital Clínic de Barcelona
2005-2011: Grade in Medicine

Publications

1. Pose E, Cardenas A. Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention. Dig Dis. 2017;35(4):402-410. doi: 10.1159/000456595. Epub 2017 May 3.

2. Pose E, Solà E, Piano S, Gola E, Graupera I, Guevara M, Cárdenas A, Angeli P, Ginès P. Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia. Real Life Experience. Am J Med. 2016 Oct 13. pii: S0002-9343(16)31017-8.doi: 10.1016/j.amjmed.2016.09.011.

3. Elia C, Graupera I, Barreto R, Solà E, Moreira R, Huelin P, Ariza X, Solé C, Pose E, Baiges A, Fabrellas N, Poch E, Fernández J, Arroyo V, Ginès P. Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: A case-control study. J Hepatol 2015;63(3):593-600. doi: 10.1016/j.jhep.2015.04.004.

4. Ezequiel Rodriguez, Gustavo Henrique Pereira, Elsa Solà, Chiara Elia, Rogelio Barreto, Elisa Pose, Jordi Colmenero, Javier Fernandez, Miquel Navasa, Vicente Arroyo, Pere Ginès. Treatment of type-2 hepatorenal syndrome in patients awaiting transplantation. Effects on kidney function and transplantation outcomes. Liver Transpl 2015; 21: 1347-54.

5. E.Solà, J.C.Kerbert, H.W.Verspaget, R.Moreira, E.Pose, P.Ruiz, R.Cela, M.Morales-Ruiz, E.López, I.Graupera, C.Solé, P.Huelin, A.Amorós Navarro, X.Ariza, R.Jalan, N.Fabrellas, D.Benten, G. de Prada, F.Durand, W.Jimenez, J.J.van der Reijden, J.Fernandez, B.van Hoek, M.J.Coenraad,P.Ginès. Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis. J Hepatol 2016. J Hepatol. 2016 Nov;65(5):914-920. doi: 10.1016/j.jhep.2016.07.003.

6. Graupera I, Solà E, Fabrellas N, Moreira R, Solé C, Huelin P, de la Prada G, Pose E, Ariza X, Risso A, Albertos S,Morales-Ruiz M, Jiménez W, Ginès P. Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis. PLoS One. 2016 Jun 30;11(6):e0157371.

7. Solé C, Solà E, Morales-Ruiz M, Fernàndez G, Huelin P, Graupera I, Moreira R, de Prada G, Ariza X, Pose E, Fabrellas N, Kalko SG, Jiménez W, Ginès P.Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis. Sci Rep. 2016 Aug 31;6:32341. doi: 10.1038/srep32341.

8. Huelin P, Piano S, Solà E, Stanco M, Solé C, Moreira R, Pose E, Fasolato S, Fabrellas N, de Prada G, Pilutti C, Graupera I, Ariza X, Romano A, Elia C, Cárdenas A, Fernández J, Angeli P, Ginès P. Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute on Chronic Liver Failure. Clin Gastroenterol Hepatol. 2016 Oct 5. pii: S1542-3565(16)30869-2. doi: 10.1016/j.cgh.2016.09.156.

9. Solà E, Sanchez-Cabús, Rodriguez, Elia C, Cela R, Moreira R, Pose E, Sánchez-Delgado J, Cañete N, Morales-Ruiz M, Campos F, Balust J, Guevara M, García-Valdecasas, Ginès P. Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites. Liver Transpl. 2017 May;23(5):583-593. doi: 10.1002/lt.24763.

10. Isabel Graupera, Mar Coll, Elisa Pose, Chiara Elia, Salvatore Piano, Elsa Solà, Delia Blaya, Patricia Huelin, Cristina Solé, Rebeca Moreira, Gloria de Prada, Núria Fabrellas, Adrià Juanola, Manuel Morales-Ruiz, Pau Sancho-Bru, Càndid Villanueva and Pere Ginès. Adipocyte Fatty Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outocomes. Sci Rep, Accepted for publication.